|
|
Novel Vanadium Complexes of Monohydroxamates for The Treatment of Type II Diabetes (ID 49410) less toxic vanadium treatment for treating type 2 diabetes There are currently no reviews for this Innovation.
| Novel Vanadium Complexes of Monohydroxamates for The Treatment of Type II Diabetes (ID 49410)
less toxic vanadium treatment for treating type 2 diabetes |
|
Novel Vanadium Complexes of Monohydroxamates for The Treatment of Type II Diabetes is a new, less toxic, oral treatment for type 2 diabetes. |
 Annual Sales Forecast for USA * | Innovation Status |
Idea |
Sales & Marketing
Support Level |
Conservative
80% odds
of selling |
Most Likely
50% odds
of selling |
Aggressive
20% odds
of selling |
Development
Status |
Proprietary
Protection Status |
Concept
Score |
| Ultra Low |
$0 |
$2,300 |
$21,000 |
2 of 5
Successful Prototypes
|
5 of 5
Granted Patent Claims
|
37 29 is
Average
|
| Low Support |
$30,000 |
$94,000 |
$240,000 |
| Medium Support |
$260,000 |
$680,000 |
$1.5 M |
| High Support |
$710,000 |
$1.9 M |
$4.0 M |
Remaining Time & Cost to First Sale |
| Ultra High |
$1.3 M |
$3.5 M |
$7.4 M |
Unknown
|
Unknown
|
Novel Vanadium Complexes of Monohydroxamates for The Treatment of Type II Diabetes (ID 49410)
- less toxic vanadium treatment for treating type 2 diabetes
Final Decision Maker: type 2 diabetes patients
Intensive studies have been carried out in the last two decades on the effects of vanadium and how it could be used in place of insulin. In vitro, vanadium salts mimic most of the effects of insulin on the main target tissues of the hormone, and in vivo they induce normal blood sugar levels, and improved glucose homeostasis in insulin-deficient and insulin-resistant diabetic rodents.
Novel Vanadium Complexes of Monohydroxamates is such a product for the treatment of type II diabetes. Vanadium salts mimic the metabolic effects of insulin through alternative insulin-independent machinery. As such vanadium therapy could make a useful, attractive and complementary approach to insulin therapy seeing that vanadium salts are less toxic and certain manipulation can be made to carry on vanadium therapy. This treatment has already shown promise in animal models and has one issued patent.
Vanadium has been shown to improve sensitivity to insulin in both Type I and Type 2 diabetes. It has been shown in human studies to have some ability to lower cholesterol levels and blood pressure.
More than 10 million Americans have diabetes mellitus, and close to a million new cases are diagnosed each year. More than 90% of these cases are of Type 2 diabetes. Dietary changes are essential to control diabetic symptoms and to avoid the many secondary complications, such as atherosclerosis, cataracts, hypertension, and renal failure.
This product was developed by a world-renowned university and research institution with an established track record of innovation and successful technology commercialization.
| $30 for one month supply | Seeking: Research, Purchase, Investment, Distribution, Manufacturing/R&D |
|
* Consumption sales forecast. Does not include "Random" events or "Inventory Fill". Forecast is for Year 1 for Large or Year 2 for Small Companies.
Forecast should be read as ..."With Low marketing support there is an 80% odds of achieving sales of at least... |
| Listing #: USA.76.031110.005 |
Page 1 of 5 |
Date Posted: 2010-04-09 |
|
| ©2008. Eureka! Institute. All Rights Reserved. Patents Granted or Pending Eureka! Ranch International www.EurekaRanch.com (513) 271-9911 |
|
Report Assumptions and Inventor(s) Commentary
|
|
| Inventor(s) Assumptions |
"Most Likely"
Estimate |
Confidence |
Inventor(s) Commentary
Data Source or Basis for Assumptions |
| # of Possible Final Decision Makers |
500,000 |
10% |
There are approx 1.6million new cases of Type 2 diabetes each year.
http://www.diabetes.org/diabetes-basics/diabetes-statistics/
|
| Revenue per First Purchase |
$30.00 |
10% |
Typical insulinomimetic supplements with vanadium salts cost around $30 on the market.
http://www.diabetes-book.com/book/chapter15_2.shtml |
| % that will Repeat |
50% |
10% |
% repeat rate dependent on consumers ability to take medication and need for it. |
| Number of Annual Repeats |
6 |
10% |
Bottles contain around 60 pills and most are taken daily. |
| Revenue per Repeat Purchase |
$30.00 |
10% |
Assuming each patient buys the same product each time. |
| Reseller (Trade) Margin |
5% |
40% |
Reseller profit margin based off industry standard. |
| Producer Profit (EBITD) |
25% |
40% |
Net profit margin based off Pharmaceutical and Medicine Manufacturing industry standard. |
| |
| Innovation Status |
|
Development
Status |
2 of 5
Successful Prototypes
|
This product has been tested in a lab setting. |
| Cost to First Sale (remaining) |
Unknown |
60% |
Cost to first sale is unknown at this time. |
| Time to First Sale (remaining) |
Unknown |
60% |
Time to first sale is unknown at this time. |
| Confidence in Concept Claims made in description |
60% |
Lab studies have been performed at a world renowned facility validating the claims. It also has a granted patent. |
Proprietary
Protection Status |
5 of 5
Granted Patent Claims
|
This product has one granted patent. |
| Concept Score & Diagnostics |
|
|
| Concept Diagnostics |
Red |
Yellow |
Green |
| Percentile Group |
Bottom 40% |
Middle 40% |
Top 20% |
| Overt Benefit |
 |
|
|
| Reason to Believe |
|
|
|
| Dramatic Difference |
|
 |
|
|
| Listing #: USA.76.031110.005 |
Page 2 of 5 |
Date Posted: 2010-04-09 |
| ©2008. Eureka! Institute. All Rights Reserved. Patents Granted or Pending Eureka! Ranch International www.EurekaRanch.com (513) 271-9911 |
|
Inventor Commentary & Alternative Development Scenarios
|
|
| Inventor(s) Sales Goals |
| Minimum Goal |
$- |
Current GOAL |
$- |
This product could be a new treatment for type 2 diabetes that is more natural and less toxic than current methods. |
Inventor(s) Commentary:
NOTE: This innovation is represented by www.yet2.com and was input by the Planet Eureka! Team who is solely responsible for its content. All cost and pricing information was estimated by the Planet Eureka! Team. To access more complete information simply click on “Link to Website With More Complete Info” or on “Email Inventor(s)” on the bottom of page 1 of this report. |
|
CURRENT SALES FORECAST |
Sales & Marketing
Support Level |
Conservative
80% odds
of selling |
Most Likely
50% odds
of selling |
Aggressive
20% odds
of selling |
| Ultra Low |
$0 |
$2,300 |
$21,000 |
| Low Support |
$30,000 |
$94,000 |
$240,000 |
| Medium Support |
$260,000 |
$680,000 |
$1.5 M |
| High Support |
$710,000 |
$1.9 M |
$4.0 M |
| Ultra High |
$1.3 M |
$3.5 M |
$7.4 M |
If MARKETING CONCEPT Improved (Increase Concept Score by +20 Points) |
Sales & Marketing
Support Level |
Conservative
80% odds
of selling |
Most Likely
50% odds
of selling |
Aggressive
20% odds
of selling |
| Ultra Low |
$0 |
$3,500 |
$32,000 |
| Low Support |
$48,000 |
$150,000 |
$370,000 |
| Medium Support |
$420,000 |
$1.1 M |
$2.3 M |
| High Support |
$1.1 M |
$3.0 M |
$6.1 M |
| Ultra High |
$2.2 M |
$5.5 M |
$11.3 M |
If PRODUCT/SERVICE Improved (Increase Repeat Rate & Number of Repeats by 30% and Revenue Per Purchase 20%) |
Sales & Marketing
Support Level |
Conservative
80% odds
of selling |
Most Likely
50% odds
of selling |
Aggressive
20% odds
of selling |
| Ultra Low |
$0 |
$3,600 |
$36,000 |
| Low Support |
$48,000 |
$160,000 |
$410,000 |
| Medium Support |
$420,000 |
$1.1 M |
$2.6 M |
| High Support |
$1.1 M |
$3.2 M |
$7.3 M |
| Ultra High |
$2.2 M |
$6.0 M |
$13.3 M |
If MARKETING CONCEPT and PRODUCT/SERVICE Improved (Increase Concept +20 Points, Repeat Rate & Number of repeats by 30% and Revenue per purchase 20%) |
Sales & Marketing
Support Level |
Conservative
80% odds
of selling |
Most Likely
50% odds
of selling |
Aggressive
20% odds
of selling |
| Ultra Low |
$0 |
$5,700 |
$57,000 |
| Low Support |
$79,000 |
$250,000 |
$650,000 |
| Medium Support |
$660,000 |
$1.8 M |
$4.0 M |
| High Support |
$1.8 M |
$4.9 M |
$11.0 M |
| Ultra High |
$3.4 M |
$9.4 M |
$20.9 M |
|
| Listing #: USA.76.031110.005 |
Page 3 of 5 |
Date Posted: 2010-04-09 |
| ©2008. Eureka! Institute. All Rights Reserved. Patents Granted or Pending Eureka! Ranch International www.EurekaRanch.com (513) 271-9911 |
|
Additional Details
|
|
| Fair Market Royalty (%) |
| |
Conservative - 80% Odds
Royalty Percentage |
Most Likely - 50% Odds
Royalty Percentage |
Aggressive - 20% Odds
Royalty Percentage |
| At CURRENT State & Status |
3.5% |
4.3% |
5.1% |
Sales & Marketing
Support Level |
Annual Inventor Royalty Revenue |
3 Year Value
to Inventor
If 50% Odds |
| 80% Odds |
50% Odds |
20% Odds |
| Ultra Low Support |
$91 |
$240 |
$450 |
$700 |
| Low Support |
$1,600 |
$3,500 |
$6,300 |
$11,000 |
| Medium Support |
$11,000 |
$24,000 |
$40,000 |
$73,000 |
| High Support |
$30,000 |
$65,000 |
$110,000 |
$190,000 |
| Ultra High Support |
$56,000 |
$120,000 |
$200,000 |
$360,000 |
| Sales & Marketing Support Level Assumptions |
| Sales & Marketing Support Level Assumptions |
Sample Numbers |
% Aware x
% Distribution
(Aware & Able) |
Inventor
Confidence |
| % Distribution |
% Awareness |
| Ultra Low Support (Word of Mouth) |
5% |
3% |
0.2% |
N/A |
| Low Support (Small Company) |
20% |
10% |
2% |
N/A |
| Medium Support (Medium Sized Company) |
50% |
25% |
13% |
N/A |
| High Support (Large Company) |
75% |
45% |
34% |
N/A |
| Ultra High Support (Mega or Niche) |
90% |
70% |
63% |
N/A |
|
Graph of EQUIVALENT (Awareness x Distribution) Combinations
 |
NAICS Industry Codes
For This Invention |
| 32541 - Pharmaceutical and Medicine Manufacturing |
| |
| |
| |
| |
|
| Patent Numbers that apply to this Product/Service |
| 6414029 |
| |
| |
| |
| |
|
| Inventor(s) PEDIGREE |
| Years EXPERIENCE in related industry |
- |
| GRANTED Patents |
5 |
| Licensing Deals SIGNED |
- |
| Innovations that have SHIPPED |
- |
|
For USA Patents: Utility Patent = 7 digit number, Design Patent starts with D, Planet Patent starts with PP. Provisional Application "61/xxx,xxx", Non provisional application "12/xxx,xxx", Design patent application "29/xxx,xxx"
|
|
CAUTION: This Merwyn Business Simulation Research Report includes no warranty or guarantee. Results and opinions should be considered rough and directional in nature. This is because the report is based upon inventor-supplied data and simplified modeling methods. If you are looking to invest, distribute, purchase or become involved with this innovation, in any way, we strongly urge you to validate the inventor data and sales forecasts BEFORE committing yourself or your resources. Merwyn Research, Inc. shall not be responsible for any liability or damages arising out of the failure to perform such investigation and validation. Changes in the concept description, product, pricing, or input assumptions will almost certainly change results.
|
| Listing #: USA.76.031110.005 |
Page 4 of 5 |
Date Posted: 2010-04-09 |
| ©2008. Eureka! Institute. All Rights Reserved. Patents Granted or Pending Eureka! Ranch International www.EurekaRanch.com (513) 271-9911 |
|
Additional Forecasts for Other Countries
|
|
 Annual Sales - Probability Forecast - Canada |
Sales & Marketing
Support Level |
Conservative
80% odds
of selling |
Most Likely
50% odds
of selling |
Aggressive
20% odds
of selling |
| Ultra Low |
$0 |
$360 |
$3,300 |
| Low Support |
$4,800 |
$15,000 |
$38,000 |
| Medium Support |
$42,000 |
$110,000 |
$230,000 |
| High Support |
$110,000 |
$300,000 |
$630,000 |
| Ultra High |
$210,000 |
$550,000 |
$1.2 M |
 Annual Sales - Probability Forecast - United Kingdom |
Sales & Marketing
Support Level |
Conservative
80% odds
of selling |
Most Likely
50% odds
of selling |
Aggressive
20% odds
of selling |
| Ultra Low |
$0 |
$640 |
$5,800 |
| Low Support |
$8,500 |
$26,000 |
$67,000 |
| Medium Support |
$74,000 |
$190,000 |
$420,000 |
| High Support |
$200,000 |
$530,000 |
$1.1 M |
| Ultra High |
$380,000 |
$980,000 |
$2.1 M |
Forecast are calculated based on population, (PPP) purchasing power parity, International Trade, Urbanization and the Human Growth Index.
Forecast can be skewed for some industries, so for best results, adjusting the number of final decision makers for every country is recommended.
| Listing #: USA.76.031110.005 |
Page 5 of 5 |
Date Posted: 2010-04-09 |
| ©2008. Eureka! Institute. All Rights Reserved. Patents Granted or Pending Eureka! Ranch International www.EurekaRanch.com (513) 271-9911 |
|
